This present study examines the expression of ANRIL in peripheral whole blood and shows that the expression of ANRIL in peripheral whole blood was significantly upregulated in DKD patients than those in healthy controls and T2DM patients. This evidence concerns the gene CDKN2B-AS1 and diabetic kidney disease.